Table:
begin	end	state
1	24	signal peptide
25	850	non-cytoplasmic
851	867	transmembrane
868	870	non-cytoplasmic
871	1073	cytoplasmic

Input:
>AO353_05630 FitnessBrowser__pseudo3_N2E3:AO353_05630
MPKRTDIKSILILGAGPIVIGQACEFDYSGAQACKALREEGYRVILVNSNPATIMTDPAM
ADATYIEPIKWQTVAKIIEKERPDALLPTMGGQTALNCALDLEREGILEKFGVEMIGANA
DTIDKAEDRSRFDKAMKSIGLACPRSGIAHSMEEANAVLEKLGFPCIIRPSFTMGGTGGG
IAYNREEFEEICARGLDLSPTKELLIDESLIGWKEYEMEVVRDKKDNCIIVCSIENFDPM
GVHTGDSITVAPAQTLTDKEYQILRNASLAVLREIGVETGGSNVQFGICPNTGRMVVIEM
NPRVSRSSALASKATGFPIAKVAAKLAVGYTLDELSNDITGGKTPASFEPSIDYVVTKLP
RFAFEKFPKADARLTTQMKSVGEVMAIGRTFQESLQKALRGLEVGVCGLDEKLDLSNPES
MSVLKRELTVPGAERIWYVADAMRAGMSVEDIFGMTMIDPWFLVQMEDLIKDEEKVKTLG
LTSIDRDMMFRLKRKGFSDQRLAKLLGVTEKSLRAHRHKLEVFPVYKRVDTCAAEFATDT
AYLYSTYEEECEAAPSGRDKIMILGGGPNRIGQGIEFDYCCVHAALALRDDGYETIMVNC
NPETVSTDYDTSDRLYFEPVTLEDVLEIVRVEKPKGVIVQYGGQTPLKLARALEAAGVPI
IGTSPDAIDRAEDRERFQQMVQRLNLRQPPNATVRSEDEAIRAAAKIGYPLVVRPSYVLG
GRAMEIVYEEEELKRYLREAVQVSNDSPVLLDHFLNCAIEMDVDAVCDGTDVVIGAIMQH
IEQAGVHSGDSACSLPPYSLPLHIQDEMREQVKKMALELGVVGLMNVQLALQGEDIYVIE
VNPRASRTVPFVSKCIGVSLAMIAARVMAGKTLKEIGFTKEIIPNFYSVKEAVFPFAKFP
GVDPILGPEMKSTGEVMGVGDTFGEAFAKAQMGASEVLPTGGTAFISVRDDDKPLVAGVA
RDLINLGFEVVATAGTAKLIEAAGLKVRRVNKVTEGRPHVVDMIKNDEVTLIINTTEGRQ
SIADSYSIRRNALQHKIYCTTTIAAGEAICEALKFGPEKTVRRLQDLHAGLKA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server